AG
COV

Aperio Group’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Aperio Group’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-130,241
Closed -$13.3M – 2049
2014
Q4 		$13.3M Buy
130,241
+3,367
+3% +$323K 0.16% 149
2014
Q3 		$11M Buy
126,874
+6,991
+6% +$619K 0.15% 170
2014
Q2 		$10.8M Buy
119,883
+10,126
+9% +$758K 0.16% 167
2014
Q1 		$8.09M Buy
+109,757
New +$7.65M 0.11% 217
2013
Q4 		– Sell
-75,814
Closed -$4.93M – 231
2013
Q3 		$4.62M Buy
75,814
+5,835
+8% +$356K 0.09% 288
2013
Q2 		$3.9M Buy
+69,979
New +$4.05M 0.09% 275

Aperio Group's COV Position: Q1 2015 in Review

Aperio Group sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 130,241 shares — an estimated $13.3M sold.

Aperio Group first reported a position in COV in Q2 2013 and held it in 6 quarters. The position peaked at $13.3M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Aperio Group reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Aperio Group sold 130,241 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $13.3M.
  • Aperio Group first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 6 quarters.
  • Aperio Group's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $13.3M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Aperio Group's 13F filing for Q1 2015, filed 29 Apr 2015.